Related Experiment Video

Updated: Apr 19, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.6K

Novel Lys63-linked ubiquitination of IKKβ induces STAT3 signaling

Leandro H Gallo1, April N Meyer, Khatereh Motamedchaboki

  • 1a Department of Chemistry and Biochemistry ; University of California San Diego ; La Jolla , CA USA.

Cell Cycle (Georgetown, Tex.)
|December 10, 2014
PubMed

Insights

Inhibitor of κB kinase β (IKKβ) is ubiquitinated, and cancer-associated mutations enhance this process. This ubiquitination platform activates STAT3 signaling, offering new therapeutic targets for cancers with upregulated NFκB signaling.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Cancer Biology

Background:

  • Nuclear Factor κB (NFκB) signaling is crucial in diseases like cancer and inflammation.
  • Inhibitor of κB (IκB) kinase β (IKKβ) regulates NFκB activation through ubiquitination.
  • Lys63-linked (K63-linked) ubiquitination is essential for upstream protein activation in NFκB pathways.

Purpose of the Study:

  • To investigate the role of IKKβ ubiquitination in NFκB signaling.
  • To identify specific ubiquitination sites on IKKβ.
  • To determine the functional consequences of IKKβ mutations and ubiquitination on signaling pathways.

Main Methods:

  • Mass spectrometry (LC-MS/MS) to identify ubiquitination sites on IKKβ.
  • Site-directed mutagenesis to study the role of specific lysine residues.
  • Inhibition of the UBC13-UEV1A complex to assess K63-linked ubiquitination.
  • Analysis of STAT3 signaling activation.

Main Results:

  • IKKβ undergoes K63-linked ubiquitination, particularly at Lys147, Lys418, Lys555, and Lys703.
  • Mutations in IKKβ (e.g., Lys171) increase kinase activation and ubiquitination.
  • IKKβ ubiquitination, especially at Lys147, is essential for STAT3 activation.
  • IKKβ activation forms a K63-ubiquitin conjugated signaling platform within the kinase domain.

Conclusions:

  • IKKβ itself is a target of K63-linked ubiquitination, forming a signaling platform.
  • Cancer-associated IKKβ mutations enhance ubiquitination and activate STAT3 signaling.
  • Targeting IKKβ ubiquitination may offer therapeutic strategies for cancers with aberrant NFκB signaling, such as Multiple Myeloma.
Keywords:
IKKβK-63 ubiquitinationNFκBSTAT3cell proliferationinflammatory signalingmass spectrometrymultiple myelomaoncogenesispolyubiquitination

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

15.7K
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF311:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

12.6K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.6K